Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 548,515
  • Shares Outstanding, K 77,147
  • Annual Sales, $ 430,900 K
  • Annual Income, $ 19,380 K
  • 60-Month Beta 1.88
  • Price/Sales 1.22
  • Price/Cash Flow 5.25
  • Price/Book 1.05
Trade BVS with:

Options Overview Details

View History
  • Implied Volatility 99.66% ( +11.56%)
  • Historical Volatility 61.52%
  • IV Percentile 89%
  • IV Rank 73.13%
  • IV High 128.21% on 05/18/22
  • IV Low 21.96% on 08/24/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 261
  • Open Int (30-Day) 744

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.16
  • Number of Estimates 2
  • High Estimate 0.17
  • Low Estimate 0.15
  • Prior Year 0.16
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.73 +8.77%
on 07/01/22
9.90 -26.02%
on 06/08/22
-1.77 (-19.47%)
since 06/03/22
3-Month
6.73 +8.77%
on 07/01/22
14.10 -48.09%
on 04/07/22
-6.44 (-46.80%)
since 04/05/22
52-Week
6.73 +8.77%
on 07/01/22
17.64 -58.50%
on 07/29/21
-9.19 (-55.66%)
since 07/02/21

Most Recent Stories

More News
Bioventus Amends CartiHeal Acquisition Structure

DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 7.39 (+3.94%)
Implied Volatility Surging for Bioventus (BVS) Stock Options

Investors need to pay close attention to Bioventus (BVS) stock based on the movements in the options market lately.

BVS : 7.39 (+3.94%)
Bioventus Inc. (BVS) Q1 2022 Earnings Call Transcript

BVS earnings call for the period ending March 31, 2022.

BVS : 7.39 (+3.94%)
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance

DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active...

BVS : 7.39 (+3.94%)
Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance

DURHAM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 7.39 (+3.94%)
Oversold Conditions For Bioventus (BVS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

BVS : 7.39 (+3.94%)
Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA

DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 7.39 (+3.94%)
Bioventus Announces $415 Million Offering of Senior Notes

DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 7.39 (+3.94%)
Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives

DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 7.39 (+3.94%)
Why Bioventus Stock Is Sinking Today

Investors aren't happy about the company's acquisition plans.

BVS : 7.39 (+3.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 7.62
2nd Resistance Point 7.36
1st Resistance Point 7.24
Last Price 7.39
1st Support Level 6.86
2nd Support Level 6.60
3rd Support Level 6.48

See More

52-Week High 17.64
Fibonacci 61.8% 13.47
Fibonacci 50% 12.18
Fibonacci 38.2% 10.90
Last Price 7.39
52-Week Low 6.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar